Treatment Overview
Mycoplasma Genitalium (M. genitalium) Testing & Treatment in Korea is a specialized medical service designed to detect and manage infections caused by the bacterium Mycoplasma genitalium. This sexually transmitted infection (STI) is increasingly recognized as a significant cause of urethritis, cervicitis, pelvic inflammatory disease (PID), and infertility. Many individuals infected with M. genitalium do not show symptoms, which increases the importance of routine testing.
Korea is recognized for its advanced laboratory testing methods and integrated STI management programs, offering accurate detection and targeted treatment plans. Clinics combine modern diagnostics with expert gynecologic care, ensuring comprehensive treatment that prioritizes both health outcomes and patient comfort.
Purpose & Benefits
The purpose of M. genitalium testing and treatment is to confirm infection early, address symptoms, and prevent long-term complications. Untreated M. genitalium infections can result in chronic pelvic pain, infertility, and increased susceptibility to other STIs, including HIV.
Key benefits include:
- Accurate detection of Mycoplasma genitalium infection.
- Timely treatment to reduce complications.
- Prevention of reproductive health issues, such as pelvic inflammatory disease.
- Reduction of STI transmission risks.
- Comprehensive sexual health assessment and counseling.
Many clinics in Korea offer Mycoplasma genitalium testing as part of broader STD/STI screening programs, enabling patients to receive full-spectrum reproductive health care.
Ideal Candidates
Mycoplasma genitalium testing is recommended for:
- Sexually active individuals, especially those with new or multiple partners.
- Individuals experiencing symptoms such as unusual discharge, painful urination, pelvic pain, or bleeding between periods.
- Women with unexplained pelvic inflammatory disease or infertility.
- Individuals diagnosed with other STIs.
- People who have had unprotected sexual contact.
Korean medical facilities provide confidential testing and treatment, ensuring patient privacy and comfort for both locals and international visitors.
Possible Risks & Complications
M. genitalium testing is safe, involving minimal discomfort. Testing generally requires a urine sample or a swab of the urethra, cervix, or rectum, depending on symptoms and medical history. Some patients may experience mild discomfort during swabbing, but this is temporary.
If untreated, M. genitalium infection can lead to:
- Pelvic inflammatory disease (PID) in women, which can cause infertility or ectopic pregnancy.
- Epididymitis in men, resulting in pain and possible fertility issues.
- Increased susceptibility to other STIs, including HIV.
- Chronic reproductive tract discomfort and inflammation.
Early detection and treatment in Korea significantly reduce these risks and improve patient outcomes.
Techniques Used
Korea employs advanced diagnostic methods for M. genitalium detection:
- Nucleic Acid Amplification Tests (NAATs) – the most sensitive and specific method, detecting bacterial DNA from urine or swab samples.
- Polymerase Chain Reaction (PCR) Testing – identifies M. genitalium with high accuracy.
- Multiplex STI Panels – simultaneous testing for M. genitalium and other common STIs for comprehensive screening.
These technologies ensure precise diagnosis, enabling tailored treatment plans and improving patient care.
Recovery & Aftercare
Treatment for Mycoplasma genitalium in Korea is generally effective and involves a course of targeted antibiotics. Due to increasing antibiotic resistance, Korean clinics often use resistance-guided therapy based on laboratory testing results. Common antibiotics include azithromycin or moxifloxacin.
Patients are advised to:
- Complete the full prescribed course of antibiotics.
- Avoid sexual activity until treatment is complete and symptoms resolve.
- Inform sexual partners so they can also be tested and treated.
- Attend follow-up appointments to confirm infection clearance.
Proper aftercare includes education on STI prevention and guidance on regular screening for reproductive health.
Results & Longevity
Accurate M. genitalium testing ensures early diagnosis and effective treatment. When treated promptly and appropriately, the infection can be completely resolved. However, reinfection is possible, so preventive measures are important.
Korea’s healthcare system offers ongoing patient follow-up to monitor for recurrence and ensure long-term reproductive health. This approach helps patients maintain sexual wellness and avoid further complications.
Treatment Process in Korea
The process for Mycoplasma genitalium Testing & Treatment in Korea is patient-centered and confidential:
- Initial consultation to review symptoms, sexual history, and risk factors.
- Sample collection using urine or swabs from the urethra, cervix, or rectum.
- Laboratory testing using advanced NAAT or PCR methods.
- Diagnosis and explanation of results with a specialist.
- Prescription of targeted antibiotics based on test results and resistance profiling.
- Follow-up testing to confirm treatment success.
Why Korea is a leading destination:
- State-of-the-art laboratories using advanced NAAT and PCR technology.
- Rapid turnaround times for test results.
- Integrated STI testing for efficient and comprehensive care.
- Expert gynecologists and infectious disease specialists.
- Confidential, patient-focused care with support for international patients.
Cost Range
The cost of Mycoplasma genitalium testing and treatment in Korea varies:
- Basic NAAT testing: ₩150,000 – ₩300,000 KRW ($120–$240 USD).
- PCR testing: ₩250,000 – ₩400,000 KRW ($200–$320 USD).
- Antibiotic treatment course: ₩100,000 – ₩250,000 KRW ($80–$200 USD).
- Comprehensive STI panels including M. genitalium: ₩500,000 – ₩900,000 KRW ($400–$700 USD).
These prices generally include consultation, testing, treatment, and follow-up care.
Popular Clinics in Korea
Leading providers of Mycoplasma Genitalium Testing & Treatment include:
- Samsung Medical Center, Seoul – advanced diagnostic and treatment services for STIs.
- Asan Medical Center, Seoul – expert in comprehensive sexual health care.
- Severance Hospital, Yonsei University – integrated STI testing and treatment programs.
- CHA Bundang Women’s Hospital – specialized in gynecologic infectious diseases.
- Ewha Womans University Medical Center – confidential and high-quality Mycoplasma genitalium testing.
- Private sexual health clinics in Gangnam – discreet, efficient, and patient-centered STI services for locals and international patients.
